This paper is in the following e-collection/theme issue:

Scoping Review Protocols (180) Pharmacology and Pharmaceutics (66)

Published on in Vol 9, No 9 (2020): September

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/17684, first published .
The Impact of Brexit on the Pharmaceutical Supply Chain of the United Kingdom: Scoping Review Protocol

The Impact of Brexit on the Pharmaceutical Supply Chain of the United Kingdom: Scoping Review Protocol

The Impact of Brexit on the Pharmaceutical Supply Chain of the United Kingdom: Scoping Review Protocol

Authors of this article:

Madison Milne-Ives1 Author Orcid Image ;   Ching Lam1 Author Orcid Image ;   Michelle van Velthoven1 Author Orcid Image ;   Edward Meinert1, 2, 3 Author Orcid Image
Article Authors Cited by (3) Tweetations (3) Metrics

Madison Milne-Ives   1 , BAS, MSc ;   Ching Lam   1 , MEng ;   Michelle van Velthoven   1 , BSc, MSc, PhD ;   Edward Meinert   1, 2, 3 , MA, MSc, MBA, MPA, PhD

1 Digitally Enabled PrevenTative Health Research Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom

2 Department of Primary Care and Public Health, Imperial College London, London, United Kingdom

3 Centre for Health Technology, Faculty of Health, University of Plymouth, Plymouth, United Kingdom

Corresponding Author:

  • Edward Meinert, MA, MSc, MBA, MPA, PhD
  • Centre for Health Technology
  • Faculty of Health
  • University of Plymouth
  • 6 Kirkby Place
  • Plymouth, PL4 8AA
  • United Kingdom
  • Phone: 44 1752600600
  • Email: edward.meinert@plymouth.ac.uk